发明名称 |
PHARMACEUTICAL FORMULATION COMPRISING LANTHANUM COMPOUND |
摘要 |
<P>PROBLEM TO BE SOLVED: To provide a chewable lanthanum formulation comprising a pharmaceutically effective amount of a lanthanum compound; and at least one chewable pharmaceutically acceptable excipient. <P>SOLUTION: There is provided a chewable lanthanum formulation comprising a pharmaceutically effective amount of a lanthanum compound and at least one chewable pharmaceutically acceptable excipient. A pharmaceutical formulation in a tablet or in a powder comprising a pharmaceutically effective amount of a lanthanum compound produced by a method which comprises the steps of: (a) powder-blending the lanthanum compound and at least one pharmaceutically acceptable excipient in a mixer to form a mixture; or (b) powder-blending the lanthanum compound and an excipient, compressing the resulting combination into a slug material or roller-compacting the resulting combination into a strand material, and milling the prepared material into a free flowing mixture; and (c) compressing the resulting mixture into a tablet or filling up the resulting mixture in an appropriate container. <P>COPYRIGHT: (C)2011,JPO&INPIT |
申请公布号 |
JP2010248247(A) |
申请公布日期 |
2010.11.04 |
申请号 |
JP20100171525 |
申请日期 |
2010.07.30 |
申请人 |
SHIRE HOLDINGS AG |
发明人 |
FERDINANDO JOSEPHINE CHRISTINE;HASLAM ROBERT PAUL;TRESPIDI LAURA ANNA |
分类号 |
A61K33/00;A61J3/10;A61K9/00;A61K9/14;A61K9/20;A61K33/24;A61K47/04;A61K47/12;A61K47/36;A61P7/00;A61P13/12 |
主分类号 |
A61K33/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|